SCHEMBL8214339

SCHEMBL8214339

Cn1nc(-c2ccccc2)c(-c2cccc3cccnc23)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
MAPT P10636 3/20 0.43
MMP2 P08253 2/20 0.43
TSHR P16473 2/20 0.43
GMNN O75496 1/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
HSP90AA1 P07900 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
MMP9 P14780 1/20 0.43
ALOX15 P16050 1/20 0.43
NFKB1 P19838 1/20 0.43
MMP8 P22894 1/20 0.43
CCR1 P32246 1/20 0.43
THPO P40225 1/20 0.43
MTOR P42345 1/20 0.43
HTT P42858 1/20 0.43
MMP13 P45452 1/20 0.43
CCR5 P51681 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13510683 0.86 HTR2C (0.44) KDM4EMAPTMMP2TSHRGMNN
SCHEMBL13509077 0.85 ATR (0.40) KDM4EMAPTMMP2TSHRGMNN
SCHEMBL8206566 0.79 DHODH (0.41) KDM4EHTTNPC1RAB9ATOP1
SCHEMBL4148271 0.77 MMP2 (0.60) KDM4EMAPTMMP2TSHRGMNN
SCHEMBL15940830 0.77 L3MBTL1 (0.54) KDM4EMAPTMMP2TSHRGMNN
SCHEMBL27816291 0.76 MMP2 (0.58) KDM4EMAPTMMP2TSHRGMNN
SCHEMBL8205966 0.75 KMT2A (0.48) KDM4EMAPTALOX15HTTSMN1; SMN2
SCHEMBL30592746 0.74 MMP2 (0.56) KDM4EMAPTMMP2TSHRGMNN
SCHEMBL12074320 0.74 MMP2 (0.56) KDM4EMAPTMMP2TSHRGMNN
Water SCHEMBL28036087 0.74 MMP2 (0.56) KDM4EMAPTMMP2TSHRGMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021960-A2 TRIAZOLYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2008-02-21 WO disclosed